10x Genomics, Inc. Class A Common Stock

TXGNASDAQUSD
35.01 USD
0.41 (1.19%)🟢LIVE (AS OF 01:36 PM EDT)
🟢Market: OPEN

TXG is currently priced at $35.01. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 24, 2026.

Open?$34.50
High?$36.65
Low?$33.63
Prev. Close?$34.60
Volume?1.3M
Avg. Volume?3.2M
VWAP?$35.42
Rel. Volume?0.40x
Bid / Ask
Bid?$35.13 × 100
Ask?$40.59 × 100
Spread?$5.46
Midpoint?$37.86
Valuation & Ratios
Market Cap?4.4B
Shares Out?116.9M
Float?114.0M
Float %?96.9%
P/E Ratio?N/A
P/B Ratio?5.39
EPS?-$0.18
Dividend?0.00%
Ex-Dividend?N/A
RelatedPACB
News
Profile
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Employees
1.2K
Market Cap
4.4B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2019-09-12
Address
6230 STONERIDGE MALL ROAD
PLEASANTON, CA 94588
Phone: (925) 401-7300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
82
Short Sent.?
70
Piotroski F-Score?3/9Weak
Altman Z-Score?12.14Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?14.47%High
Short Interest?16.5M
Days to Cover?5.5
Free Float114.0M
Avg Daily Volume3.0M
Settlement Date2026-05-29
Financial Health
Current Ratio?5.90Strong
Quick Ratio?5.42Strong
Cash Ratio?4.32Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
60/100
P/E?
N/A
P/B?
Peers
100
S&P
34
5.39FAIR
P/S?
Peers
50
S&P
18
6.88FAIR
P/FCF?
S&P
20
36.0PRICEY
EV/EBITDA?
S&P
97
-90.6CHEAP
EV/Sales?
Peers
100
S&P
27
6.11HIGH
Returns & Efficiency
ROE?
S&P
13
-2.8%WEAK
ROA?
S&P
3
-2.2%WEAK
Cash Flow & Enterprise
FCF?$122.2M
Enterprise Value?$3.9B
Fundamentals ratios updated end of day